These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16926119)

  • 1. "Initial, continuous and intermittent bolus" administration of minimally-diluted blood cardioplegia supplemented with potassium and magnesium for hypertrophied hearts.
    Hayashi Y; Ohtani M; Hiraishi T; Kobayashi Y; Nakamura T
    Heart Lung Circ; 2006 Oct; 15(5):325-31. PubMed ID: 16926119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial, continuous and intermittent bolus cardioplegia administration: efficacy of potassium-chloride and magnesium-sulfate as minimal additives for minimally-diluted blood cardioplegia.
    Hayashi Y; Ohtani M; Sawa Y; Hiraishi T; Akedo H; Kobayashi Y; Nakamura T; Matsuda H
    J Cardiovasc Surg (Torino); 2005 Feb; 46(1):61-8. PubMed ID: 15758880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally-diluted blood cardioplegia supplemented with potassium and magnesium for combination of 'initial, continuous and intermittent bolus' administration.
    Hayashi Y; Ohtani M; Sawa Y; Hiraishi T; Akedo H; Kobayashi Y; Matsuda H
    Circ J; 2004 May; 68(5):467-72. PubMed ID: 15118290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of continuous warm blood cardioplegia in cardiac valve re-replacement.
    Nagaoka H; Hirooka K; Ohnuki M; Fujiwara N
    J Heart Valve Dis; 1999 Mar; 8(2):124-30. PubMed ID: 10224569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous warm versus intermittent cold cardioplegic infusion: a comparison of energy metabolism, sodium-potassium adenosine triphosphatase activity, and postischemic functional recovery in the blood-perfused rat heart.
    Qiu Y; Galiñanes M; Haddock PS; Hcarse DJ
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):797-805. PubMed ID: 8800170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial large-dose administration of modified St. Thomas' solution.
    Hiraoka A; Nakajima K; Kuinose M; Totsugawa T; Yoshitaka H
    Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):267-71. PubMed ID: 24585900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrograde versus antegrade delivery of cardioplegic solution in myocardial revascularization. A clinical trial in patients with three-vessel coronary artery disease who underwent myocardial revascularization with extensive use of the internal mammary artery.
    Noyez L; van Son JA; van der Werf T; Knape JT; Gimbrère J; van Asten WN; Lacquet LK; Flameng W
    J Thorac Cardiovasc Surg; 1993 May; 105(5):854-63. PubMed ID: 8487564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of a non-potassium modified maintenance solution to enhance myocardial protection in stressed neonatal hearts: a new approach.
    Kronon MT; Allen BS; Halldorsson A; Rahman S; Barth MJ; Ilbawi M
    J Thorac Cardiovasc Surg; 2002 Jan; 123(1):119-29. PubMed ID: 11782765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of retrograde continuous tepid blood cardioplegia for myocardial remodeling.
    Fujii T; Watanabe Y; Shiono N; Kawasaki M; Yokomuro H; Ozawa T; Hamada S; Masuhara H; Teramoto C; Hara M; Katayanagi T; Sasaki Y; Koyama N
    Ann Thorac Cardiovasc Surg; 2006 Dec; 12(6):397-403. PubMed ID: 17228277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Dose Lignocaine-Based Blood Cardioplegia in Single Valve Replacement Patients.
    Ramani J; Malhotra A; Wadhwa V; Sharma P; Garg P; Tarsaria M; Pandya H
    Braz J Cardiovasc Surg; 2017; 32(2):90-95. PubMed ID: 28492789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of cold blood cardioplegia and cold crystalloid cardioplegia with or without magnesium].
    Kuraoka S; Orita H; Shimanuki T; Kohno M; Fukasawa M; Inui K; Washio M
    Rinsho Kyobu Geka; 1989 Apr; 9(2):173-5. PubMed ID: 9301915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between intermittent retrograde cold blood cardioplegia and retrograde crystalloid cardioplegia].
    Yamazaki I; Yano Y; Kondo J; Matsumoto A; Kurata H; Soma T
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Apr; 44(4):467-71. PubMed ID: 8666863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortic valve replacement: better myocardial protection by cold or warm retrograde blood cardioplegia?
    Boening A; Sanuri M; Buchwald D; Laczkovics AM
    J Heart Valve Dis; 1996 May; 5(3):273-80. PubMed ID: 8793675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
    Maruyama Y; Chambers DJ
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):745-9. PubMed ID: 18550603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective cardiac surgery using Celsior or St. Thomas No. 2 solution: a prospective, single-center, randomized pilot study.
    Pereda D; Castella M; Pomar JL; Cartaña R; Josa M; Barriuso C; Roman J; Mulet J
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):501-6. PubMed ID: 17604178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury.
    Feindel CM; Tait GA; Wilson GJ; Klement P; MacGregor DC
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):585-95. PubMed ID: 6708578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium. Clinical study in comparison with St. Thomas' Hospital solution.
    Kinoshita K; Oe M; Tokunaga K
    J Thorac Cardiovasc Surg; 1991 Apr; 101(4):695-702. PubMed ID: 2008108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.